FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3211659864> ?p ?o ?g. }

• W3211659864 endingPage "9950" @default.
• W3211659864 startingPage "9939" @default.
• W3211659864 abstract "Agonists of the stimulator of interferon gene (STING) are considered as promising therapeutics for cancer immunotherapy. However, drug-delivery barriers and adverse effects limit the clinical application of STING agonists. Therefore, it is an urgent need to develop an ideal delivery system to deliver STING agonists and avoid side effects. Here, we discovered that STING agonists significantly stimulated type I interferon (IFN) secretion in Clec9a+ dendritic cells (DCs). Then, we designed an engineered peptide-expressed biomimetic cancer cell membrane (EPBM)-coated nanovaccine drug-delivery system (PLGA/STING@EPBM) to deliver STING agonists and tumor antigens to Clec9a+ DCs. The PLGA/STING@EPBM nanovaccine significantly enhanced IFN-stimulated expression of genes and antigen cross-presentation of Clec9a+ DCs, thus eliciting strong antitumor effects in both anti-PD-1-responsive and -resistant tumor models without obvious cytotoxicity. Moreover, the PLGA/STING@EPBM nanovaccine combined with radiotherapy exhibited remarkable synergistic antitumor effects. Our work highlights the great potential of a EPBM-coated nanovaccine for systemic STING agonist delivery as an attractive tool for cancer immunotherapy." @default.
• W3211659864 created "2021-11-22" @default.
• W3211659864 creator A5006901857 @default.
• W3211659864 creator A5016795467 @default.
• W3211659864 creator A5022120736 @default.
• W3211659864 creator A5024747900 @default.
• W3211659864 creator A5044208918 @default.
• W3211659864 creator A5063046811 @default.
• W3211659864 creator A5065001210 @default.
• W3211659864 creator A5066707494 @default.
• W3211659864 creator A5072713326 @default.
• W3211659864 creator A5090260832 @default.
• W3211659864 date "2021-11-15" @default.
• W3211659864 modified "2023-10-12" @default.
• W3211659864 title "Engineered Nanovaccine Targeting Clec9a⁺ Dendritic Cells Remarkably Enhances the Cancer Immunotherapy Effects of STING Agonist" @default.
• W3211659864 cites W1839872679 @default.
• W3211659864 cites W1912124796 @default.
• W3211659864 cites W1984539398 @default.
• W3211659864 cites W1999020268 @default.
• W3211659864 cites W2072691337 @default.
• W3211659864 cites W2127144270 @default.
• W3211659864 cites W2131388477 @default.
• W3211659864 cites W2161684993 @default.
• W3211659864 cites W2165838507 @default.
• W3211659864 cites W2168028214 @default.
• W3211659864 cites W2237126693 @default.
• W3211659864 cites W2294356527 @default.
• W3211659864 cites W2296705508 @default.
• W3211659864 cites W2335924114 @default.
• W3211659864 cites W2404096427 @default.
• W3211659864 cites W2466965232 @default.
• W3211659864 cites W2567813843 @default.
• W3211659864 cites W2606608340 @default.
• W3211659864 cites W2780622257 @default.
• W3211659864 cites W2804447831 @default.
• W3211659864 cites W2890875511 @default.
• W3211659864 cites W2900220188 @default.
• W3211659864 cites W2903337853 @default.
• W3211659864 cites W2909554490 @default.
• W3211659864 cites W2914277167 @default.
• W3211659864 cites W2936435806 @default.
• W3211659864 cites W2944980090 @default.
• W3211659864 cites W2946298500 @default.
• W3211659864 cites W2948559837 @default.
• W3211659864 cites W2964717223 @default.
• W3211659864 cites W2965208844 @default.
• W3211659864 cites W2972159813 @default.
• W3211659864 cites W2981712207 @default.
• W3211659864 cites W2982520686 @default.
• W3211659864 cites W2988506530 @default.
• W3211659864 cites W2991398148 @default.
• W3211659864 cites W2994331021 @default.
• W3211659864 cites W2995171541 @default.
• W3211659864 cites W2999198943 @default.
• W3211659864 cites W3007151837 @default.
• W3211659864 cites W3011282656 @default.
• W3211659864 cites W3014768524 @default.
• W3211659864 cites W3022163387 @default.
• W3211659864 cites W3036571927 @default.
• W3211659864 cites W3048940241 @default.
• W3211659864 cites W3053604026 @default.
• W3211659864 cites W3061136593 @default.
• W3211659864 cites W3080399909 @default.
• W3211659864 cites W3080665560 @default.
• W3211659864 cites W3089941770 @default.
• W3211659864 cites W3108059276 @default.
• W3211659864 cites W3108623682 @default.
• W3211659864 cites W3108901914 @default.
• W3211659864 cites W3126746996 @default.
• W3211659864 cites W3166404219 @default.
• W3211659864 cites W4237901336 @default.
• W3211659864 doi "https://doi.org/10.1021/acs.nanolett.1c03243" @default.
• W3211659864 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34779631" @default.
• W3211659864 hasPublicationYear "2021" @default.
• W3211659864 type Work @default.
• W3211659864 sameAs 3211659864 @default.
• W3211659864 citedByCount "35" @default.
• W3211659864 countsByYear W32116598642022 @default.
• W3211659864 countsByYear W32116598642023 @default.
• W3211659864 crossrefType "journal-article" @default.
• W3211659864 hasAuthorship W3211659864A5006901857 @default.
• W3211659864 hasAuthorship W3211659864A5016795467 @default.
• W3211659864 hasAuthorship W3211659864A5022120736 @default.
• W3211659864 hasAuthorship W3211659864A5024747900 @default.
• W3211659864 hasAuthorship W3211659864A5044208918 @default.
• W3211659864 hasAuthorship W3211659864A5063046811 @default.
• W3211659864 hasAuthorship W3211659864A5065001210 @default.
• W3211659864 hasAuthorship W3211659864A5066707494 @default.
• W3211659864 hasAuthorship W3211659864A5072713326 @default.
• W3211659864 hasAuthorship W3211659864A5090260832 @default.
• W3211659864 hasConcept C126322002 @default.
• W3211659864 hasConcept C127413603 @default.
• W3211659864 hasConcept C136449434 @default.
• W3211659864 hasConcept C146978453 @default.
• W3211659864 hasConcept C147483822 @default.
• W3211659864 hasConcept C170493617 @default.
• W3211659864 hasConcept C185592680 @default.
• W3211659864 hasConcept C203014093 @default.

• next